Structure

Physi-Chem Properties

Molecular Weight:  614.29
Volume:  638.49
LogP:  5.135
LogD:  2.452
LogS:  -3.785
# Rotatable Bonds:  5
TPSA:  120.11
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.397
Synthetic Accessibility Score:  5.371
Fsp3:  0.514
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.142
MDCK Permeability:  1.5280038496712223e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.04
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.132

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.075
Plasma Protein Binding (PPB):  91.33644104003906%
Volume Distribution (VD):  0.974
Pgp-substrate:  4.200850963592529%

ADMET: Metabolism

CYP1A2-inhibitor:  0.017
CYP1A2-substrate:  0.804
CYP2C19-inhibitor:  0.284
CYP2C19-substrate:  0.79
CYP2C9-inhibitor:  0.808
CYP2C9-substrate:  0.206
CYP2D6-inhibitor:  0.062
CYP2D6-substrate:  0.589
CYP3A4-inhibitor:  0.903
CYP3A4-substrate:  0.894

ADMET: Excretion

Clearance (CL):  11.414
Half-life (T1/2):  0.21

ADMET: Toxicity

hERG Blockers:  0.212
Human Hepatotoxicity (H-HT):  0.173
Drug-inuced Liver Injury (DILI):  0.419
AMES Toxicity:  0.03
Rat Oral Acute Toxicity:  0.985
Maximum Recommended Daily Dose:  0.928
Skin Sensitization:  0.505
Carcinogencity:  0.79
Eye Corrosion:  0.003
Eye Irritation:  0.03
Respiratory Toxicity:  0.987

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC103816

Natural Product ID:  NPC103816
Common Name*:   Dichrostachine M
IUPAC Name:   (4aR,8R,8aS)-8-[[(1R,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-3-oxo-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl]-8a-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)-3-methoxy-7-methyl-5,8-dihydro-4aH-naphthalene-1,4-dione
Synonyms:   Dichrostachine M
Standard InCHIKey:  NWFRZQVUFDCHQD-CTGSLWKSSA-N
Standard InCHI:  InChI=1S/C37H42O8/c1-19-9-10-22-34(42)29(44-7)18-31(41)37(22,32-17-27(40)33-26(39)13-21(43-6)14-28(33)45-32)23(19)15-24-20(2)25(38)16-30-35(3,4)11-8-12-36(24,30)5/h9,13-14,17-18,22-24,30,39H,2,8,10-12,15-16H2,1,3-7H3/t22-,23+,24-,30-,36+,37-/m0/s1
SMILES:  COC1=CC(=O)[C@@]2([C@H](C1=O)CC=C([C@H]2C[C@H]1C(=C)C(=O)C[C@@H]2[C@]1(C)CCCC2(C)C)C)c1cc(=O)c2c(o1)cc(cc2O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1077625
PubChem CID:   44557283
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15669 Dichrostachys cinerea Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19761234]
NPO15669 Dichrostachys cinerea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 3.1 uM PMID[522558]
NPT2 Others Unspecified IC50 = 3000.0 nM PMID[522558]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC103816 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC61382
0.9744 High Similarity NPC17274
0.9744 High Similarity NPC85047
0.9744 High Similarity NPC120857
0.962 High Similarity NPC20734
0.962 High Similarity NPC286074
0.962 High Similarity NPC54903
0.956 High Similarity NPC193698
0.9441 High Similarity NPC469393
0.9367 High Similarity NPC469395
0.9161 High Similarity NPC470353
0.913 High Similarity NPC469394
0.9108 High Similarity NPC470354
0.9108 High Similarity NPC192587
0.9108 High Similarity NPC470352
0.9079 High Similarity NPC472447
0.9079 High Similarity NPC472446
0.9062 High Similarity NPC475106
0.9013 High Similarity NPC473812
0.9013 High Similarity NPC473813
0.8987 High Similarity NPC56049
0.8987 High Similarity NPC54830
0.8951 High Similarity NPC314653
0.8951 High Similarity NPC316262
0.8875 High Similarity NPC90497
0.8841 High Similarity NPC193222
0.8824 High Similarity NPC204469
0.882 High Similarity NPC195136
0.8812 High Similarity NPC474637
0.878 High Similarity NPC476255
0.878 High Similarity NPC476056
0.8758 High Similarity NPC105584
0.8735 High Similarity NPC313717
0.8735 High Similarity NPC315306
0.8734 High Similarity NPC305965
0.8712 High Similarity NPC94796
0.8704 High Similarity NPC475107
0.8704 High Similarity NPC43490
0.8704 High Similarity NPC472618
0.8704 High Similarity NPC121647
0.8704 High Similarity NPC313368
0.8696 High Similarity NPC201127
0.8683 High Similarity NPC477529
0.8679 High Similarity NPC154683
0.8679 High Similarity NPC40356
0.8671 High Similarity NPC188403
0.8667 High Similarity NPC62444
0.8662 High Similarity NPC470460
0.8659 High Similarity NPC131578
0.8654 High Similarity NPC178343
0.8654 High Similarity NPC329678
0.8654 High Similarity NPC5820
0.8654 High Similarity NPC306488
0.865 High Similarity NPC476929
0.8645 High Similarity NPC11700
0.8645 High Similarity NPC158874
0.8642 High Similarity NPC15815
0.8642 High Similarity NPC472617
0.8642 High Similarity NPC125969
0.8642 High Similarity NPC295090
0.8636 High Similarity NPC232021
0.8636 High Similarity NPC40118
0.8636 High Similarity NPC126534
0.8631 High Similarity NPC475080
0.8625 High Similarity NPC214632
0.8625 High Similarity NPC324447
0.8623 High Similarity NPC476196
0.8616 High Similarity NPC178484
0.8616 High Similarity NPC81474
0.8614 High Similarity NPC223413
0.8614 High Similarity NPC470377
0.8614 High Similarity NPC478059
0.8614 High Similarity NPC76647
0.8614 High Similarity NPC478060
0.8614 High Similarity NPC471975
0.8614 High Similarity NPC470374
0.8608 High Similarity NPC470461
0.8608 High Similarity NPC471114
0.8599 High Similarity NPC259632
0.859 High Similarity NPC273538
0.859 High Similarity NPC326500
0.859 High Similarity NPC216538
0.859 High Similarity NPC476055
0.859 High Similarity NPC117716
0.859 High Similarity NPC470674
0.859 High Similarity NPC234629
0.859 High Similarity NPC311741
0.859 High Similarity NPC470673
0.8589 High Similarity NPC286422
0.8589 High Similarity NPC226462
0.8589 High Similarity NPC98023
0.8581 High Similarity NPC325346
0.8581 High Similarity NPC297600
0.858 High Similarity NPC272196
0.858 High Similarity NPC271741
0.858 High Similarity NPC257166
0.858 High Similarity NPC287789
0.858 High Similarity NPC1796
0.8571 High Similarity NPC100049
0.8571 High Similarity NPC14606
0.8571 High Similarity NPC205026
0.8571 High Similarity NPC52611
0.8571 High Similarity NPC215203
0.8571 High Similarity NPC159707
0.8571 High Similarity NPC265178
0.8571 High Similarity NPC158027
0.8571 High Similarity NPC79375
0.8571 High Similarity NPC186227
0.8571 High Similarity NPC150908
0.8571 High Similarity NPC265624
0.8571 High Similarity NPC118128
0.8571 High Similarity NPC37253
0.8571 High Similarity NPC121649
0.8571 High Similarity NPC248739
0.8571 High Similarity NPC476159
0.8563 High Similarity NPC41598
0.8563 High Similarity NPC63514
0.8563 High Similarity NPC55422
0.8563 High Similarity NPC40089
0.8563 High Similarity NPC476146
0.8563 High Similarity NPC158329
0.8563 High Similarity NPC47634
0.8563 High Similarity NPC75141
0.8563 High Similarity NPC476216
0.8562 High Similarity NPC25427
0.8554 High Similarity NPC125465
0.8554 High Similarity NPC251336
0.8553 High Similarity NPC29777
0.8553 High Similarity NPC471115
0.8545 High Similarity NPC476931
0.8544 High Similarity NPC152233
0.8544 High Similarity NPC39195
0.8544 High Similarity NPC145467
0.8544 High Similarity NPC296869
0.8544 High Similarity NPC244407
0.8544 High Similarity NPC266572
0.8537 High Similarity NPC219686
0.8537 High Similarity NPC189552
0.8537 High Similarity NPC273467
0.8535 High Similarity NPC477955
0.8535 High Similarity NPC473135
0.8535 High Similarity NPC124729
0.8535 High Similarity NPC470676
0.8535 High Similarity NPC470458
0.8535 High Similarity NPC473132
0.8535 High Similarity NPC299011
0.8528 High Similarity NPC18699
0.8528 High Similarity NPC55443
0.8528 High Similarity NPC228654
0.8528 High Similarity NPC51247
0.8526 High Similarity NPC293053
0.8526 High Similarity NPC212932
0.8526 High Similarity NPC9117
0.8526 High Similarity NPC19896
0.8526 High Similarity NPC24821
0.8526 High Similarity NPC190637
0.8521 High Similarity NPC476229
0.8521 High Similarity NPC474276
0.8521 High Similarity NPC73899
0.8521 High Similarity NPC17105
0.8521 High Similarity NPC147363
0.8521 High Similarity NPC471969
0.8521 High Similarity NPC476152
0.8521 High Similarity NPC476139
0.8519 High Similarity NPC309648
0.8519 High Similarity NPC32867
0.8519 High Similarity NPC198489
0.8519 High Similarity NPC61112
0.8516 High Similarity NPC136840
0.8516 High Similarity NPC282300
0.8516 High Similarity NPC262094
0.8516 High Similarity NPC90582
0.8516 High Similarity NPC110969
0.8509 High Similarity NPC71061
0.8509 High Similarity NPC329844
0.8509 High Similarity NPC290830
0.8509 High Similarity NPC303485
0.8509 High Similarity NPC121568
0.8509 High Similarity NPC194593
0.8509 High Similarity NPC72425
0.8506 High Similarity NPC49242
0.8503 High Similarity NPC286230
0.8503 High Similarity NPC253730
0.85 High Similarity NPC478148
0.85 High Similarity NPC476162
0.8494 Intermediate Similarity NPC169471
0.8494 Intermediate Similarity NPC189689
0.8491 Intermediate Similarity NPC65775
0.8491 Intermediate Similarity NPC65589
0.8491 Intermediate Similarity NPC288036
0.8491 Intermediate Similarity NPC97029
0.8491 Intermediate Similarity NPC291746
0.8491 Intermediate Similarity NPC10027
0.8491 Intermediate Similarity NPC158338
0.8491 Intermediate Similarity NPC100985
0.8491 Intermediate Similarity NPC269420
0.8491 Intermediate Similarity NPC288840
0.8491 Intermediate Similarity NPC97028
0.8485 Intermediate Similarity NPC473022
0.8481 Intermediate Similarity NPC14001

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC103816 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.859 High Similarity NPD4378 Clinical (unspecified phase)
0.8571 High Similarity NPD8443 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD7075 Discontinued
0.8282 Intermediate Similarity NPD7819 Suspended
0.8235 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.821 Intermediate Similarity NPD6599 Discontinued
0.8204 Intermediate Similarity NPD6959 Discontinued
0.8171 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD7411 Suspended
0.8153 Intermediate Similarity NPD2800 Approved
0.8129 Intermediate Similarity NPD1510 Phase 2
0.8117 Intermediate Similarity NPD6651 Approved
0.811 Intermediate Similarity NPD6801 Discontinued
0.8101 Intermediate Similarity NPD3750 Approved
0.8098 Intermediate Similarity NPD4380 Phase 2
0.8089 Intermediate Similarity NPD1549 Phase 2
0.8077 Intermediate Similarity NPD2796 Approved
0.8072 Intermediate Similarity NPD7768 Phase 2
0.8025 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7473 Discontinued
0.8 Intermediate Similarity NPD1607 Approved
0.7987 Intermediate Similarity NPD1240 Approved
0.7975 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD3882 Suspended
0.7962 Intermediate Similarity NPD6100 Approved
0.7962 Intermediate Similarity NPD6099 Approved
0.7953 Intermediate Similarity NPD6166 Phase 2
0.7953 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD6799 Approved
0.7917 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD3749 Approved
0.7875 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD1512 Approved
0.7844 Intermediate Similarity NPD2801 Approved
0.7844 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD7808 Phase 3
0.7836 Intermediate Similarity NPD6232 Discontinued
0.7805 Intermediate Similarity NPD5403 Approved
0.7798 Intermediate Similarity NPD3817 Phase 2
0.779 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD3748 Approved
0.7784 Intermediate Similarity NPD7251 Discontinued
0.773 Intermediate Similarity NPD1511 Approved
0.7727 Intermediate Similarity NPD6797 Phase 2
0.7711 Intermediate Similarity NPD3226 Approved
0.7692 Intermediate Similarity NPD5402 Approved
0.7683 Intermediate Similarity NPD2534 Approved
0.7683 Intermediate Similarity NPD2532 Approved
0.7683 Intermediate Similarity NPD5401 Approved
0.7683 Intermediate Similarity NPD2533 Approved
0.7679 Intermediate Similarity NPD1934 Approved
0.7667 Intermediate Similarity NPD8434 Phase 2
0.7647 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7390 Discontinued
0.7616 Intermediate Similarity NPD5494 Approved
0.7614 Intermediate Similarity NPD7054 Approved
0.7593 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD2344 Approved
0.7571 Intermediate Similarity NPD7472 Approved
0.7571 Intermediate Similarity NPD7074 Phase 3
0.7562 Intermediate Similarity NPD2799 Discontinued
0.7557 Intermediate Similarity NPD3818 Discontinued
0.7546 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD5953 Discontinued
0.7527 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1551 Phase 2
0.75 Intermediate Similarity NPD7458 Discontinued
0.7486 Intermediate Similarity NPD3926 Phase 2
0.7485 Intermediate Similarity NPD1243 Approved
0.7473 Intermediate Similarity NPD8150 Discontinued
0.7458 Intermediate Similarity NPD3751 Discontinued
0.7444 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD4628 Phase 3
0.7439 Intermediate Similarity NPD7003 Approved
0.7416 Intermediate Similarity NPD5844 Phase 1
0.7405 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD8313 Approved
0.7403 Intermediate Similarity NPD8312 Approved
0.7394 Intermediate Similarity NPD2309 Approved
0.7391 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD4908 Phase 1
0.7381 Intermediate Similarity NPD920 Approved
0.7362 Intermediate Similarity NPD1471 Phase 3
0.7356 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD1465 Phase 2
0.7326 Intermediate Similarity NPD5761 Phase 2
0.7326 Intermediate Similarity NPD5760 Phase 2
0.7318 Intermediate Similarity NPD7286 Phase 2
0.7301 Intermediate Similarity NPD2935 Discontinued
0.7296 Intermediate Similarity NPD2313 Discontinued
0.7296 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD6559 Discontinued
0.7292 Intermediate Similarity NPD7435 Discontinued
0.7292 Intermediate Similarity NPD7697 Approved
0.7292 Intermediate Similarity NPD7696 Phase 3
0.7292 Intermediate Similarity NPD7698 Approved
0.7273 Intermediate Similarity NPD1247 Approved
0.7262 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD2798 Approved
0.7257 Intermediate Similarity NPD919 Approved
0.7256 Intermediate Similarity NPD2346 Discontinued
0.7254 Intermediate Similarity NPD7870 Phase 2
0.7254 Intermediate Similarity NPD7871 Phase 2
0.7247 Intermediate Similarity NPD2403 Approved
0.7246 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6779 Approved
0.7225 Intermediate Similarity NPD6776 Approved
0.7225 Intermediate Similarity NPD6781 Approved
0.7225 Intermediate Similarity NPD6778 Approved
0.7225 Intermediate Similarity NPD6780 Approved
0.7225 Intermediate Similarity NPD6777 Approved
0.7225 Intermediate Similarity NPD6782 Approved
0.7197 Intermediate Similarity NPD1470 Approved
0.7194 Intermediate Similarity NPD8151 Discontinued
0.7188 Intermediate Similarity NPD3268 Approved
0.7184 Intermediate Similarity NPD4288 Approved
0.717 Intermediate Similarity NPD6832 Phase 2
0.7157 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7157 Intermediate Similarity NPD7874 Approved
0.7151 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4360 Phase 2
0.7143 Intermediate Similarity NPD4363 Phase 3
0.7143 Intermediate Similarity NPD7701 Phase 2
0.7135 Intermediate Similarity NPD3787 Discontinued
0.7135 Intermediate Similarity NPD5711 Approved
0.7135 Intermediate Similarity NPD5710 Approved
0.7126 Intermediate Similarity NPD8166 Discontinued
0.7121 Intermediate Similarity NPD7801 Approved
0.7118 Intermediate Similarity NPD6273 Approved
0.7115 Intermediate Similarity NPD3972 Approved
0.7099 Intermediate Similarity NPD943 Approved
0.7095 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1203 Approved
0.7089 Intermediate Similarity NPD2797 Approved
0.7077 Intermediate Similarity NPD8319 Approved
0.7077 Intermediate Similarity NPD8320 Phase 1
0.707 Intermediate Similarity NPD4749 Approved
0.7051 Intermediate Similarity NPD1610 Phase 2
0.7047 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7229 Phase 3
0.7031 Intermediate Similarity NPD7700 Phase 2
0.7031 Intermediate Similarity NPD7699 Phase 2
0.703 Intermediate Similarity NPD4308 Phase 3
0.703 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD4287 Approved
0.7016 Intermediate Similarity NPD4361 Phase 2
0.7016 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD9717 Approved
0.6988 Remote Similarity NPD5404 Approved
0.6988 Remote Similarity NPD5405 Approved
0.6988 Remote Similarity NPD5406 Approved
0.6988 Remote Similarity NPD5408 Approved
0.6983 Remote Similarity NPD8127 Discontinued
0.6978 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6978 Remote Similarity NPD7228 Approved
0.6977 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6975 Remote Similarity NPD3764 Approved
0.6971 Remote Similarity NPD37 Approved
0.6966 Remote Similarity NPD6234 Discontinued
0.6964 Remote Similarity NPD2654 Approved
0.6963 Remote Similarity NPD6534 Approved
0.6963 Remote Similarity NPD6535 Approved
0.6951 Remote Similarity NPD6355 Discontinued
0.6951 Remote Similarity NPD5124 Phase 1
0.6951 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6949 Remote Similarity NPD4967 Phase 2
0.6949 Remote Similarity NPD4966 Approved
0.6949 Remote Similarity NPD4965 Approved
0.6943 Remote Similarity NPD422 Phase 1
0.6943 Remote Similarity NPD1201 Approved
0.6943 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6941 Remote Similarity NPD7236 Approved
0.6933 Remote Similarity NPD8032 Phase 2
0.6928 Remote Similarity NPD7033 Discontinued
0.6919 Remote Similarity NPD6104 Discontinued
0.6914 Remote Similarity NPD4625 Phase 3
0.6914 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6903 Remote Similarity NPD1548 Phase 1
0.6893 Remote Similarity NPD2296 Approved
0.6893 Remote Similarity NPD7907 Approved
0.6889 Remote Similarity NPD7199 Phase 2
0.6875 Remote Similarity NPD3266 Approved
0.6875 Remote Similarity NPD3267 Approved
0.6871 Remote Similarity NPD6798 Discontinued
0.6866 Remote Similarity NPD7783 Phase 2
0.6866 Remote Similarity NPD7782 Clinical (unspecified phase)
0.686 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6848 Remote Similarity NPD230 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data